vs
太平洋生物科学（ASMB）与Foghorn Therapeutics Inc.（FHTX）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是Foghorn Therapeutics Inc.的1.2倍（$10.8M vs $9.2M），太平洋生物科学净利率更高（-85.2% vs -234.3%，领先149.0%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs 57.6%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
ASMB vs FHTX — 直观对比
营收规模更大
ASMB
是对方的1.2倍
$9.2M
营收增速更快
FHTX
高出166.2%
57.6%
净利率更高
ASMB
高出149.0%
-234.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $9.2M |
| 净利润 | $-9.2M | $-21.7M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | -258.2% |
| 净利率 | -85.2% | -234.3% |
| 营收同比 | 57.6% | 223.8% |
| 净利润同比 | 4.3% | -11.1% |
| 每股收益（稀释后） | $-0.72 | $-0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBFHTX
| Q4 25 | — | $9.2M | ||
| Q3 25 | $10.8M | $8.2M | ||
| Q2 25 | $9.6M | $7.6M | ||
| Q1 25 | $9.4M | $6.0M | ||
| Q4 24 | $7.4M | $2.9M | ||
| Q3 24 | $6.8M | $7.8M | ||
| Q2 24 | $8.5M | $6.9M | ||
| Q1 24 | $5.8M | $5.0M |
净利润ASMBFHTX
| Q4 25 | — | $-21.7M | ||
| Q3 25 | $-9.2M | $-15.8M | ||
| Q2 25 | $-10.2M | $-17.9M | ||
| Q1 25 | $-8.8M | $-18.8M | ||
| Q4 24 | — | $-19.5M | ||
| Q3 24 | $-9.6M | $-19.1M | ||
| Q2 24 | $-11.2M | $-23.0M | ||
| Q1 24 | $-9.1M | $-25.0M |
营业利润率ASMBFHTX
| Q4 25 | — | -258.2% | ||
| Q3 25 | -100.9% | -226.9% | ||
| Q2 25 | -115.2% | -279.2% | ||
| Q1 25 | -105.5% | -385.0% | ||
| Q4 24 | — | -840.5% | ||
| Q3 24 | -160.1% | -305.5% | ||
| Q2 24 | -143.0% | -386.6% | ||
| Q1 24 | -185.5% | -558.3% |
净利率ASMBFHTX
| Q4 25 | — | -234.3% | ||
| Q3 25 | -85.2% | -194.4% | ||
| Q2 25 | -105.9% | -237.3% | ||
| Q1 25 | -93.6% | -316.4% | ||
| Q4 24 | — | -682.9% | ||
| Q3 24 | -140.4% | -244.9% | ||
| Q2 24 | -130.7% | -333.6% | ||
| Q1 24 | -156.9% | -495.4% |
每股收益（稀释后）ASMBFHTX
| Q4 25 | — | $-0.35 | ||
| Q3 25 | $-0.72 | $-0.25 | ||
| Q2 25 | $-1.33 | $-0.28 | ||
| Q1 25 | $-1.17 | $-0.30 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | $-1.51 | $-0.31 | ||
| Q2 24 | $-1.98 | $-0.45 | ||
| Q1 24 | $-1.66 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $80.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $-108.5M |
| 总资产 | $240.0M | $198.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBFHTX
| Q4 25 | — | $80.9M | ||
| Q3 25 | $22.5M | $89.3M | ||
| Q2 25 | $24.0M | $72.6M | ||
| Q1 25 | $23.4M | $61.0M | ||
| Q4 24 | $38.3M | $55.5M | ||
| Q3 24 | $28.5M | $57.7M | ||
| Q2 24 | $19.2M | $138.9M | ||
| Q1 24 | $18.7M | $79.3M |
股东权益ASMBFHTX
| Q4 25 | — | $-108.5M | ||
| Q3 25 | $182.7M | $-89.7M | ||
| Q2 25 | $18.1M | $-76.7M | ||
| Q1 25 | $27.1M | $-61.7M | ||
| Q4 24 | $33.4M | $-45.5M | ||
| Q3 24 | $26.0M | $-28.3M | ||
| Q2 24 | $34.7M | $-14.3M | ||
| Q1 24 | $32.6M | $-97.5M |
总资产ASMBFHTX
| Q4 25 | — | $198.1M | ||
| Q3 25 | $240.0M | $205.0M | ||
| Q2 25 | $80.8M | $226.2M | ||
| Q1 25 | $99.0M | $258.7M | ||
| Q4 24 | $119.2M | $284.0M | ||
| Q3 24 | $100.3M | $308.4M | ||
| Q2 24 | $115.3M | $328.6M | ||
| Q1 24 | $119.9M | $255.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-22.3M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBFHTX
| Q4 25 | — | $-22.3M | ||
| Q3 25 | $-15.1M | $-18.9M | ||
| Q2 25 | $-16.8M | $-21.0M | ||
| Q1 25 | $-23.4M | $-24.0M | ||
| Q4 24 | $-51.1M | $-24.5M | ||
| Q3 24 | $-15.2M | $-21.0M | ||
| Q2 24 | $-17.1M | $-25.5M | ||
| Q1 24 | $-18.4M | $-29.3M |
自由现金流ASMBFHTX
| Q4 25 | — | — | ||
| Q3 25 | $-15.2M | — | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | — | $-24.0M | ||
| Q4 24 | $-51.1M | $-25.0M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | $-17.1M | $-25.6M | ||
| Q1 24 | $-18.4M | $-29.4M |
自由现金流率ASMBFHTX
| Q4 25 | — | — | ||
| Q3 25 | -140.7% | — | ||
| Q2 25 | — | -278.2% | ||
| Q1 25 | — | -403.2% | ||
| Q4 24 | -695.2% | -875.3% | ||
| Q3 24 | — | -273.0% | ||
| Q2 24 | -200.6% | -371.0% | ||
| Q1 24 | -317.7% | -583.1% |
资本支出强度ASMBFHTX
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.0% | 0.5% | ||
| Q4 24 | 0.4% | 16.8% | ||
| Q3 24 | 0.0% | 4.0% | ||
| Q2 24 | 0.2% | 0.2% | ||
| Q1 24 | 0.2% | 2.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
